Skip to main content

Weight Loss-Driven Remission of Prediabetes Tied to Lower Type 2 Diabetes Risk

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Oct. 11, 2023 -- Weight loss-driven remission of prediabetes protects against type 2 diabetes and is associated with better kidney and vascular function, according to a study published online Sept. 25 in The Lancet Diabetes & Endocrinology.

Arvid Sandforth, M.D., from the University of Tübingen in Germany, and colleagues investigated the mechanisms of weight loss-induced remission in people with prediabetes. The analysis included participants in the Prediabetes Lifestyle Intervention Study (PLIS) and the Diabetes Prevention Program (DPP) study who were randomly assigned to receive a lifestyle intervention or placebo and who lost at least 5 percent of their body weight. Responders were defined as those who returned to normal fasting plasma glucose, normal glucose tolerance, and hemoglobin A1c (HbA1c) <39 mmol/mol after 12 months of lifestyle intervention or placebo or control intervention.

The researchers found that in PLIS, 25.7 percent of participants had weight loss of 5 percent or more of their body weight from baseline, and of these, 43 percent were responders. Among the 683 DPP participants who lost at least 5 percent of their body weight at baseline, 19 percent were responders. While body mass index reduction was similar between responders and nonresponders, whole-body insulin sensitivity increased more in responders than in nonresponders, but insulin secretion did not differ within groups over time or between groups. Intrahepatic lipid content decreased similarly in responders and nonresponders, but visceral adipose tissue decreased more in responders. In the two years after the intervention, responders had a 73 percent lower risk for developing type 2 diabetes than nonresponders.

"We suggest that remission of prediabetes should be the primary therapeutic aim in individuals with prediabetes," the authors write.

Several authors disclosed ties to industry.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted October 2023

Read this next

First Responders With More Debris Exposure Have Higher Risk of Early Dementia

FRIDAY, June 14, 2024 -- More severe exposure to dust or debris among World Trade Center (WTC) responders is significantly associated with a higher risk of dementia at <65...

1990 to 2019 Saw Increase in Life Expectancy in Seniors With T1DM

FRIDAY, June 14, 2024 -- From 1990 to 2019, there was an increase in life expectancy in older people with type 1 diabetes mellitus (T1DM), according to a study published online...

Second Tumors Are Rare After Chimeric Antigen Receptor T-Cell Therapy

FRIDAY, June 14, 2024 -- Second tumors are rarely seen after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the June 13 issue of the New England...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.